interleukin-4 PE38KDEL cytotoxin
NBI-3001-ST-0101
Phase 1 mab completed
Quick answer
interleukin-4 PE38KDEL cytotoxin for Breast Cancer is a Phase 1 program (mab) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Breast Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed